** Shares of medical device maker AngioDynamics ANGO.O rise 31.6% to $12.37
** ANGO now expects 2025 adj. loss per share between $0.34 and $0.38, down from its prior projection of between $0.38 and $0.42
** Company continues to expect net sales in the range of $282 mln to $288 mln
** Posts Q2 net sales of $73 mln, up 9.2%
** Stock had risen ~17% in 2024
(Reporting by Juby Babu in Mexico City)
((Juby.Babu@thomsonreuters.com))